<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <version>1.0.0</version>
    <cboCostEstimates />
    <relatedBills>
      <item>
        <latestAction>
          <text>Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.</text>
          <actionDate>2017-03-02</actionDate>
        </latestAction>
        <type>HR</type>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
        <congress>115</congress>
        <number>878</number>
        <latestTitle>Right to Try Act of 2017</latestTitle>
      </item>
      <item>
        <latestAction>
          <text>Became Public Law No: 115-176.</text>
          <actionDate>2018-05-30</actionDate>
        </latestAction>
        <type>S</type>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
        <congress>115</congress>
        <number>204</number>
        <latestTitle>Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017</latestTitle>
      </item>
    </relatedBills>
    <amendments />
    <summaries>
      <billSummaries>
        <item>
          <versionCode>00</versionCode>
          <text><![CDATA[<p><b>Right to Try Act</b></p> <p>This bill requires the federal government to allow unrestricted manufacturing, distribution, prescribing, and dispensing of experimental drugs, biological products, and medical devices that are authorized by state law and intended to treat terminally ill patients. Patients receiving these treatments must be certified by a physician as having exhausted all other treatment options and as being at greater risk from their medical condition than the treatment. The physician must explain the treatment to the patient, including that the treatment is experimental, and the patient, or the patient's legal representative, must acknowledge the explanation.</p> <p>A manufacturer, distributor, prescriber, dispenser, possessor, or user of such a treatment has no liability regarding the treatment.</p> <p>The outcome of manufacture, distribution, prescribing, dispensing, possession, or use of such a treatment may not be used by a federal agency to adversely impact review or approval of the treatment.</p> <p>The treatment must: (1) have successfully completed a phase 1 (initial, small scale) clinical trial; (2) remain under investigation in a clinical trial approved by the Food and Drug Administration (FDA); and (3) not be approved, licensed, or cleared for sale by the FDA.</p> <ul> </ul>]]></text>
          <actionDate>2017-05-04</actionDate>
          <lastSummaryUpdateDate>2018-01-19T17:35:28Z</lastSummaryUpdateDate>
          <actionDesc>Introduced in House</actionDesc>
          <updateDate>2017-05-04T04:00:00Z</updateDate>
          <name>Introduced in House</name>
        </item>
      </billSummaries>
    </summaries>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <sponsors>
      <item>
        <firstName>Brian</firstName>
        <middleName>K.</middleName>
        <state>PA</state>
        <bioguideId>F000466</bioguideId>
        <identifiers>
          <bioguideId>F000466</bioguideId>
          <gpoId />
          <lisID>2345</lisID>
        </identifiers>
        <district>8</district>
        <fullName>Rep. Fitzpatrick, Brian K. [R-PA-8]</fullName>
        <party>R</party>
        <lastName>Fitzpatrick</lastName>
        <byRequestType />
      </item>
    </sponsors>
    <notes />
    <billNumber>2368</billNumber>
    <constitutionalAuthorityStatementText><![CDATA[<pre>[Congressional Record Volume 163, Number 77 (Thursday, May 4, 2017)]From the Congressional Record Online through the Government Publishing Office [<a href='http://www.gpo.gov'>www.gpo.gov</a>]By Mr. FITZPATRICK:H.R. 2368.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8, Clause 3[Page H4179]</pre>]]></constitutionalAuthorityStatementText>
    <updateDate>2019-11-15T21:34:23Z</updateDate>
    <titles>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <chamberCode />
        <title>To authorize the use of experimental drugs, biological products, and devices by patients diagnosed with a terminal illness in accordance with State law, and for other purposes.</title>
        <parentTitleType />
        <chamberName />
      </item>
      <item>
        <titleType>Short Titles as Introduced</titleType>
        <chamberCode />
        <title>Right to Try Act</title>
        <parentTitleType />
        <chamberName />
      </item>
      <item>
        <titleType>Display Title</titleType>
        <chamberCode />
        <title>Right to Try Act</title>
        <parentTitleType />
        <chamberName />
      </item>
      <item>
        <titleType>(Extracted from GPO) Short Titles as Introduced</titleType>
        <chamberCode />
        <title>Right to Try Act</title>
        <parentTitleType />
        <chamberName />
      </item>
    </titles>
    <createDate>2017-05-05T03:11:54Z</createDate>
    <title>Right to Try Act</title>
    <textVersions>
      <item>
        <type>Introduced in House</type>
        <date>2017-05-04T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-115hr2368ih/xml/BILLS-115hr2368ih.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <recordedVotes />
    <calendarNumbers />
    <committeeReports />
    <congress>115</congress>
    <latestAction>
      <actionDate>2017-06-07</actionDate>
      <links />
      <text>Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.</text>
    </latestAction>
    <actions>
      <actionByCounts>
        <houseOfRepresentatives>8</houseOfRepresentatives>
      </actionByCounts>
      <item>
        <actionDate>2017-06-07</actionDate>
        <committee>
          <systemCode>hsju08</systemCode>
          <name>Crime, Terrorism, and Homeland Security Subcommittee</name>
        </committee>
        <links />
        <sourceSystem>
          <name>House committee actions</name>
          <code>1</code>
        </sourceSystem>
        <text>Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2017-06-07</actionDate>
        <committee>
          <systemCode>hsju10</systemCode>
          <name>Constitution, Civil Rights, and Civil Liberties Subcommittee</name>
        </committee>
        <links />
        <sourceSystem>
          <name>House committee actions</name>
          <code>1</code>
        </sourceSystem>
        <text>Referred to the Subcommittee on the Constitution and Civil Justice.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2017-05-05</actionDate>
        <committee>
          <systemCode>hsif14</systemCode>
          <name>Health Subcommittee</name>
        </committee>
        <links />
        <sourceSystem>
          <name>House committee actions</name>
          <code>1</code>
        </sourceSystem>
        <text>Referred to the Subcommittee on Health.</text>
        <type>Committee</type>
      </item>
      <item>
        <committee>
          <systemCode>hsju00</systemCode>
          <name>Judiciary Committee</name>
        </committee>
        <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        <actionDate>2017-05-04</actionDate>
        <actionCode>H11100</actionCode>
        <type>IntroReferral</type>
        <links />
        <sourceSystem>
          <name>House floor actions</name>
          <code>2</code>
        </sourceSystem>
      </item>
      <item>
        <committee />
        <type>IntroReferral</type>
        <actionDate>2017-05-04</actionDate>
        <actionCode>H11100-A</actionCode>
        <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        <links />
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
      </item>
      <item>
        <committee>
          <systemCode>hsif00</systemCode>
          <name>Energy and Commerce Committee</name>
        </committee>
        <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        <actionDate>2017-05-04</actionDate>
        <actionCode>H11100</actionCode>
        <type>IntroReferral</type>
        <links />
        <sourceSystem>
          <name>House floor actions</name>
          <code>2</code>
        </sourceSystem>
      </item>
      <item>
        <committee />
        <type>IntroReferral</type>
        <actionDate>2017-05-04</actionDate>
        <actionCode>Intro-H</actionCode>
        <text>Introduced in House</text>
        <links />
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
      </item>
      <item>
        <committee />
        <type>IntroReferral</type>
        <actionDate>2017-05-04</actionDate>
        <actionCode>1000</actionCode>
        <text>Introduced in House</text>
        <links />
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
      </item>
      <actionTypeCounts>
        <billReferralsAggregate>1</billReferralsAggregate>
        <placeholderTextForH>3</placeholderTextForH>
        <introducedInHouse>1</introducedInHouse>
        <billReferrals>2</billReferrals>
        <introducedInTheHouse>1</introducedInTheHouse>
      </actionTypeCounts>
    </actions>
    <originChamber>House</originChamber>
    <committees>
      <billCommittees>
        <item>
          <type>Standing</type>
          <subcommittees>
            <item>
              <name>Crime, Terrorism, and Homeland Security Subcommittee</name>
              <systemCode>hsju08</systemCode>
              <activities>
                <item>
                  <name>Referred to</name>
                  <date>2017-06-07T18:15:17Z</date>
                </item>
              </activities>
            </item>
            <item>
              <name>Constitution, Civil Rights, and Civil Liberties Subcommittee</name>
              <systemCode>hsju10</systemCode>
              <activities>
                <item>
                  <name>Referred to</name>
                  <date>2017-06-07T18:14:49Z</date>
                </item>
              </activities>
            </item>
          </subcommittees>
          <systemCode>hsju00</systemCode>
          <name>Judiciary Committee</name>
          <chamber>House</chamber>
          <activities>
            <item>
              <name>Referred to</name>
              <date>2017-05-04T13:03:30Z</date>
            </item>
          </activities>
        </item>
        <item>
          <type>Standing</type>
          <subcommittees>
            <item>
              <name>Health Subcommittee</name>
              <systemCode>hsif14</systemCode>
              <activities>
                <item>
                  <name>Referred to</name>
                  <date>2017-05-05T20:23:16Z</date>
                </item>
              </activities>
            </item>
          </subcommittees>
          <systemCode>hsif00</systemCode>
          <name>Energy and Commerce Committee</name>
          <chamber>House</chamber>
          <activities>
            <item>
              <name>Referred to</name>
              <date>2017-05-04T13:03:25Z</date>
            </item>
          </activities>
        </item>
      </billCommittees>
    </committees>
    <introducedDate>2017-05-04</introducedDate>
    <subjects>
      <billSubjects>
        <legislativeSubjects>
          <item>
            <name>Civil actions and liability</name>
          </item>
          <item>
            <name>Drug safety, medical device, and laboratory regulation</name>
          </item>
          <item>
            <name>Drug therapy</name>
          </item>
          <item>
            <name>Health personnel</name>
          </item>
          <item>
            <name>Health technology, devices, supplies</name>
          </item>
          <item>
            <name>Licensing and registrations</name>
          </item>
          <item>
            <name>Long-term, rehabilitative, and terminal care</name>
          </item>
          <item>
            <name>Medical tests and diagnostic methods</name>
          </item>
          <item>
            <name>Prescription drugs</name>
          </item>
          <item>
            <name>Product safety and quality</name>
          </item>
        </legislativeSubjects>
        <policyArea>
          <name>Health</name>
        </policyArea>
      </billSubjects>
    </subjects>
    <cosponsors>
      <item>
        <district>9</district>
        <state>AZ</state>
        <sponsorshipDate>2017-05-04</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <identifiers>
          <lisID>2099</lisID>
          <gpoId />
          <bioguideId>S001191</bioguideId>
        </identifiers>
        <middleName />
        <sponsorshipWithdrawnDate />
        <party>D</party>
        <lastName>Sinema</lastName>
        <bioguideId>S001191</bioguideId>
        <fullName>Rep. Sinema, Kyrsten [D-AZ-9]</fullName>
        <firstName>Kyrsten</firstName>
      </item>
      <item>
        <district>5</district>
        <state>AZ</state>
        <sponsorshipDate>2017-05-04</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <identifiers>
          <lisID>2307</lisID>
          <gpoId />
          <bioguideId>B001302</bioguideId>
        </identifiers>
        <middleName />
        <sponsorshipWithdrawnDate />
        <party>R</party>
        <lastName>Biggs</lastName>
        <bioguideId>B001302</bioguideId>
        <fullName>Rep. Biggs, Andy [R-AZ-5]</fullName>
        <firstName>Andy</firstName>
      </item>
      <item>
        <district>1</district>
        <state>SC</state>
        <sponsorshipDate>2017-07-17</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <identifiers>
          <bioguideId>S000051</bioguideId>
          <gpoId />
          <lisID>1012</lisID>
        </identifiers>
        <middleName />
        <sponsorshipWithdrawnDate />
        <party>R</party>
        <lastName>Sanford</lastName>
        <bioguideId>S000051</bioguideId>
        <fullName>Rep. Sanford, Mark [R-SC-1]</fullName>
        <firstName>Mark</firstName>
      </item>
      <item>
        <district>16</district>
        <state>PA</state>
        <sponsorshipDate>2017-07-27</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <identifiers>
          <bioguideId>S001199</bioguideId>
          <gpoId />
          <lisID>2346</lisID>
        </identifiers>
        <middleName />
        <sponsorshipWithdrawnDate />
        <party>R</party>
        <lastName>Smucker</lastName>
        <bioguideId>S001199</bioguideId>
        <fullName>Rep. Smucker, Lloyd [R-PA-16]</fullName>
        <firstName>Lloyd</firstName>
      </item>
      <item>
        <district>2</district>
        <state>WV</state>
        <sponsorshipDate>2018-02-06</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <identifiers>
          <lisID>2277</lisID>
          <gpoId />
          <bioguideId>M001195</bioguideId>
        </identifiers>
        <middleName>X.</middleName>
        <sponsorshipWithdrawnDate />
        <party>R</party>
        <lastName>Mooney</lastName>
        <bioguideId>M001195</bioguideId>
        <fullName>Rep. Mooney, Alexander X. [R-WV-2]</fullName>
        <firstName>Alexander</firstName>
      </item>
    </cosponsors>
    <billType>HR</billType>
    <laws />
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

